ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,460.48
-0.41%
US Tech 100
19,181.60
-0.43%
Dow Jones
39,118.86
-0.12%
Brent Oil
84.85
0.00%
Bitcoin
61,528.49
1.05%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
08/17/20238:00AMBusiness WireGSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail PharmaciesNYSE:GSKGSK plc
08/10/202312:07PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
08/09/202311:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
08/02/20233:03AMDow Jones NewsHaleon Raises Guidance After Revenue Grew Ahead of ExpectationsNYSE:GSKGSK plc
08/01/202311:58AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/31/20232:42PMBusiness WireJemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancerNYSE:GSKGSK plc
07/31/20232:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/31/20231:45PMDow Jones NewsGSK's Endometrial Cancer Treatment Gets Further FDA ApprovalNYSE:GSKGSK plc
07/28/202310:47AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/26/202310:56AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/26/20236:27AMDow Jones NewsTrending: GSK Raises Guidance After Crowd-Pleasing 2Q OutperformanceNYSE:GSKGSK plc
07/26/20233:02AMDow Jones NewsGSK PLC Raises 2023 Guidance After 2Q Net Profit BeatNYSE:GSKGSK plc
07/25/20238:50AMIH Market NewsTuesday’s Wall Street Highlights: GM, TSMC, Spotify, F5 Networks and moreNYSE:GSKGSK plc
07/24/20236:51AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/24/20232:53AMDow Jones NewsGSK Says HIV Drug Recommended for Marketing Authorization in EuropeNYSE:GSKGSK plc
07/14/20237:51AMIH Market NewsFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and moreNYSE:GSKGSK plc
07/13/20238:23AMBusiness WireGSK is first to ship influenza vaccine doses for the 2023-24 flu season in USNYSE:GSKGSK plc
06/28/202311:42AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
06/28/202310:59AMPR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéNYSE:GSKGSK plc
06/28/202310:57AMPR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthNYSE:GSKGSK plc
06/27/20238:42AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/27/20232:46AMDow Jones NewsGSK Gonorrhoea Vaccine Candidate Gets FDA Fast-Track DesignationNYSE:GSKGSK plc
06/26/20237:24AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/26/20237:21AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/26/20232:51AMDow Jones NewsGSK Shingles Vaccine Shingrix Approved in Japan for Adults Over 18NYSE:GSKGSK plc
06/26/20232:43AMDow Jones NewsGSK's Chronic Kidney Disease Treatment Gets Positive CHMP OpinionNYSE:GSKGSK plc
06/23/202311:30AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/23/202311:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/23/20236:35AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/23/20235:34AMDow Jones NewsTrending: GSK Agrees Confidential Settlement Over Zantac LitigationNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
GRST
Ethema Health (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
AABB
Asia Broadband (PK)
COIN
BTCUSD
Bitcoin
USOTC
SPZI
Spooz (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
FFIE
Faraday Future Intellige...
NASDAQ
COOP
Mr Cooper
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
EMGE
Emergent Health (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
BLEG
Branded Legacy (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved